Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Gestational Trophoblastic Disease 6Ovarian Neoplasms 2Teratoma, Ovarian 1Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Hydatidiform Mole, Invasive 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Choriocarcinoma 1Chondrosarcoma 1

Interventions

Filgrastim 4Carboplatin 3belinostat 2Peripheral Blood Stem Cell Transplantation 2Ifosfamide 2Etoposide 2resiquimod 1poly ICLC 1etoposide phosphate 1capivasertib 1Vincristine 1Topotecan 1Thiotepa 1Taxes 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiotherapy 1Radiosurgery 1Quality of Life 1Pentetic Acid 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Nutritional Support 1Molecular Diagnostic Techniques 1Minocycline 1Immunotherapy 1Immunologic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Dactinomycin × Gynecologic × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡